Global Transplant Diagnostics Market - Global Forecasts to 2019 - Published by MarketsandMarkets

Share Article

In the global transplant diagnostics market, leading players are adopting the strategies of new product development, new product launches, agreements, partnerships, collaborations, geographic expansions, acquisitions and joint ventures. http://www.marketsandmarkets.com/Market-Reports/transplant-diagnostics-market-96374742.html

MarketsandMarkets

MarketsandMarkets

The Key Players are Abbott Laboratories Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche, Ltd. (Switzerland), Illumina, Inc. (U.S.), Immucor, Inc. (U.S.), Linkage Biosciences (U.S.), Olerup Ssp Ab (Norway), Qiagen N.V. (Netherlands).

The global transplant diagnostics market was dominated by Thermo Fisher Scientific Inc. (U.S.), Immucor, Inc. (U.S.), Olerup Ssp Ab (Norway), Qiagen N.V. (Netherlands), Bio-Rad Laboratories Inc. (U.S.) and Abbott Laboratories Inc. (U.S.) in 2013. These six companies together accounted for a share of ~89.0% of the global transplant diagnostics market in 2013. Thermo Fisher Scientific Inc. was the leader in this market in 2013 and is expected to lead the market in the next five years as well. The company has a broad product portfolio for transplant diagnostics products (particularly HLA typing products), including state-of-the-art instruments (such as Ion PGM Dx System, 3500 Dx Genetic Analyzers, Veriti Dx PCR Thermal Cycler and QuantStudio Dx Real-Time PCR system), reagents (such as antibody detection products, molecular typing products, serology products, human and rabbit compliment and biomarker panels), consumables (pipettes, vials and bottles) and software. The company employs more than 50,000 people and operates its businesses through more than 200 subsidiaries spread around the world. The company has a strong market foothold in more than 50 countries across the globe that enables it to maintain its leading position in the global transplant diagnostics market. Furthermore, the company focuses on new product launches and strategic acquisitions as its key business strategy to ensure its growth in the global transplant diagnostics market.

Inquiries on This Report @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=96374742
Immucor, Inc. held the second position in the global transplant diagnostics market in 2013. Over the past three years, the company has been focusing on strategic acquisitions and collaborations as its key business strategies, in order to increase its share in the global transplant diagnostics market. The company has a wide product portfolio with a number of advanced HLA typing instruments, reagent kits, consumables and softwares, which serves as an important factor for its future growth. Capture-P system, LIFECODES Fluoroanalyzer and LIFECODES family of reagents and HLA typing kits are technologically advanced product brands offered by the company. The company operates its businesses in matured markets including the U.S., Germany, Italy, Japan, Canada, Belgium, France, Portugal, the U.K., India and Spain.

About MarketsandMarkets
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @http://www.marketsandmarkets.com/Subscription.html

Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441 FREE
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mr. Rohan
@marketsmarkets
since: 04/2009
Follow >
Market Research Report
since: 12/2010
Like >
Visit website